The present invention relates to novel compounds prepared from readily accessible 3-O-propargyl-D-galactopyranoside derivatives and having an effect as i.a., galectin inhibitors, the use of said compounds as a medicament as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to ligands in a mammal, wherein said galectin is preferably a galectin-3. The novel compounds are defined by the general formula (I).
US9353141B2
申请人:——
公开号:US9353141B2
公开(公告)日:2016-05-31
[EN] NOVEL GALACTOSIDE INHIBITORS OF GALECTINS<br/>[FR] NOUVEAUX INHIBITEURS GALACTOSIDES DE GALECTINES
申请人:GALECTO BIOTECH AB
公开号:WO2013110704A1
公开(公告)日:2013-08-01
The present invention relates to novel compounds prepared from readily accessible 3-O-propargyl-D-galactopyranoside derivatives and having an effect as i.a., galectin inhibitors, the use of said compounds as a medicament as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to ligandsin a mammal, wherein said galectin is preferably a galectin-3. The novel compounds are defined by the general formula (I).